Département des risques biologiques et de la santé au travail, Institut National de Santé Publique du Québec (INSPQ) , Québec, Canada.
Axe Maladies infectieuses et immunitaires, Centre de Recherche du CHU de Québec-Université Laval , Québec, Canada.
Hum Vaccin Immunother. 2021 Feb 1;17(2):451-456. doi: 10.1080/21645515.2020.1775456. Epub 2020 Jul 9.
Describe Ontario's school-based human papillomavirus (HPV) vaccination program from the perspective of local public health units (PHUs).
In 2018, Vaccine Preventable Diseases (VPD) managers at each of Ontario's 35 PHUs were invited to participate in an online survey regarding the organization and delivery of their HPV vaccination program. Questions were asked on the school-based program, training and support of vaccine providers, communication and promotion, assessing coverage rates and perceptions of the program's strengths and challenges. Descriptive statistics were generated for close-ended items. A thematic content analysis was performed for open-ended items.
Eighteen PHUs (54%, n = 19/35) responded. All responding PHUs provided the HPV vaccine in publicly funded schools but only 6 reported being permitted to provide HPV vaccine in private schools. Fact sheets, Q&As or other written information locally developed by the PHUs were the main tools used to communicate with parents (n = 17), students (n = 13), school personnel (n = 13) and school board officials (n = 9). The most frequently reported barriers were: limited program resources, negative perceptions held by parents and/or school staff regarding the HPV vaccine, logistical issues (e.g., getting the consents forms returned, collaboration with schools for vaccine delivery) and the fact that HPV vaccination is not mandatory under Ontario legislation.
Local public health units that implement HPV vaccine programs in schools identified logistical barriers, public perceptions about the HPV vaccine and the voluntary nature of the program as the main barriers.
从当地公共卫生单位（PHU）的角度描述安大略省的学校人乳头瘤病毒（HPV）疫苗接种计划。
2018 年，安大略省 35 个 PHU 的疫苗可预防疾病（VPD）经理受邀参加了一项关于其 HPV 疫苗接种计划的组织和实施的在线调查。问题涉及基于学校的计划、疫苗提供者的培训和支持、沟通和推广、评估覆盖率以及对该计划优势和挑战的看法。对封闭式问题进行了描述性统计分析。对开放式问题进行了主题内容分析。
18 个 PHU（54%，n=19/35）做出了回应。所有做出回应的 PHU 都在公立学校提供 HPV 疫苗，但只有 6 个报告称被允许在私立学校提供 HPV 疫苗。由 PHU 本地制定的情况说明书、问答或其他书面信息是与家长（n=17）、学生（n=13）、学校人员（n=13）和学校董事会官员（n=9）沟通的主要工具。报告的主要障碍包括：计划资源有限、家长和/或学校工作人员对 HPV 疫苗的负面看法、后勤问题（例如，让同意书返回、与学校合作进行疫苗接种）以及安大略省立法规定 HPV 疫苗接种不是强制性的。
在学校实施 HPV 疫苗接种计划的当地公共卫生单位确定了后勤障碍、公众对 HPV 疫苗的看法以及该计划的自愿性质是主要障碍。
